TY - JOUR
T1 - Infection Prevention and Antimicrobial Stewardship Program Collaboration During the COVID-19 Pandemic
T2 - a Window of Opportunity
AU - Assi, Mariam
AU - Abbas, Salma
AU - Nori, Priya
AU - Doll, Michelle
AU - Godbout, Emily
AU - Bearman, Gonzalo
AU - Stevens, Michael P.
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2021/10
Y1 - 2021/10
N2 - Purpose of Review: We describe the similarities between antimicrobial stewardship programs (ASPs) and infection prevention programs (IPPs), and we discuss how these similarities lend themselves to synergy between programs. We also discuss how the COVID-19 pandemic has generated further opportunities for future collaborations that could benefit both programs. Recent Findings: The COVID-19 pandemic has created new needs, such as real-time data and access to personnel important to both programs, such as information technologists and infectious diseases specialists. It has also increased concerns about rising rates of antimicrobial resistance and healthcare-associated infections, both of which overlap significantly and are key focus areas for both ASPs and IPPs. These emergent issues have highlighted the need for enhanced program infrastructure and new team models. The shift towards telecommunication and telework has facilitated the creation of enhanced infrastructures for collaboration on activities ranging from data access and reporting to providing telehealth services to remote hospitals. These enhanced infrastructures can be leveraged in future collaborative efforts between ASPs and IPPs. Summary: Collaboration between IPPs and ASPs can mitigate setbacks experienced by health systems during the current pandemic, enhance the performance of both programs in the post-pandemic era and increase their preparedness for future pandemic threats. As health systems plan for the post-pandemic era, they should invest in opportunities for synergy between ASPs and IPPs highlighted during the pandemic.
AB - Purpose of Review: We describe the similarities between antimicrobial stewardship programs (ASPs) and infection prevention programs (IPPs), and we discuss how these similarities lend themselves to synergy between programs. We also discuss how the COVID-19 pandemic has generated further opportunities for future collaborations that could benefit both programs. Recent Findings: The COVID-19 pandemic has created new needs, such as real-time data and access to personnel important to both programs, such as information technologists and infectious diseases specialists. It has also increased concerns about rising rates of antimicrobial resistance and healthcare-associated infections, both of which overlap significantly and are key focus areas for both ASPs and IPPs. These emergent issues have highlighted the need for enhanced program infrastructure and new team models. The shift towards telecommunication and telework has facilitated the creation of enhanced infrastructures for collaboration on activities ranging from data access and reporting to providing telehealth services to remote hospitals. These enhanced infrastructures can be leveraged in future collaborative efforts between ASPs and IPPs. Summary: Collaboration between IPPs and ASPs can mitigate setbacks experienced by health systems during the current pandemic, enhance the performance of both programs in the post-pandemic era and increase their preparedness for future pandemic threats. As health systems plan for the post-pandemic era, they should invest in opportunities for synergy between ASPs and IPPs highlighted during the pandemic.
KW - Antimicrobial stewardship
KW - COVID-19
KW - Coronavirus disease 2019
KW - Infection prevention
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85112817890&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112817890&partnerID=8YFLogxK
U2 - 10.1007/s11908-021-00759-w
DO - 10.1007/s11908-021-00759-w
M3 - Review article
AN - SCOPUS:85112817890
SN - 1523-3847
VL - 23
JO - Current Infectious Disease Reports
JF - Current Infectious Disease Reports
IS - 10
M1 - 15
ER -